Breaking News Instant updates and real-time market news.

FGEN

FibroGen

$37.60 /

+2.2 (+6.21%)

, ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

07:16
05/21/20
05/21
07:16
05/21/20
07:16

Astellas Pharma receives EMA acceptance for roxadustat MAA

Astellas Pharma (ALPMY) and FibroGen (FGEN) announced the marketing authorization application for roxadustat for the treatment of anemia in adult patients with chronic kidney disease (CKD) has been accepted by the European Medicines Agency for regulatory review. The MAA is supported by positive results from a pivotal Phase 3 program, which involved more than 9,000 patients worldwide. The MAA dossier includes the DOLOMITES study, the results of which will be disclosed later this year.8,9 Results from these studies support roxadustat as efficacious in increasing and maintaining target hemoglobin levels with reduced use of intravenous iron in adult patients with CKD anemia, both those who are dialysis dependent and those non-dialysis dependent. These data also support a favorable risk:benefit profile with cardiovascular and general safety of roxadustat reflective of the underlying conditions of the CKD population. EMA's acceptance of the roxadustat MAA for treatment of anemia in adult patients with CKD on dialysis and not on dialysis triggers a milestone payment of $130 million by Astellas to FibroGen.

FGEN

FibroGen

$37.60 /

+2.2 (+6.21%)

ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

  • 04

    Jun

  • 20

    Dec

FGEN FibroGen
$37.60 /

+2.2 (+6.21%)

05/06/20 RBC Capital
Akebia price target raised to $12 from $8 at RBC Capital
05/05/20 Piper Sandler
Piper Sandler remains a buyer of Akebia following Phase 3 INNO2VATE data
05/05/20 Piper Sandler
Piper says efficacy, safety of FibroGen, Akebia drugs 'quite similar' in DD-CKD
05/05/20 Piper Sandler
Piper sees Akebia shares having 'nice follow through' on pre-market upside
ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

01/23/20 Morgan Stanley
Astellas Pharma resumed with an Overweight at Morgan Stanley
12/05/19 JPMorgan
Audentes Therapeutics downgraded to Neutral from Overweight at JPMorgan
12/03/19 Raymond James
Audentes downgraded to Market Perform from Outperform at Raymond James
12/03/19 H.C. Wainwright
Audentes Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

TODAY'S FREE FLY STORIES

Recommendations
Global Blood launch of Oxbryta tracking favorably, says Piper Sandler » 05:12
05/27/20
05/27
05:12
05/27/20
05:12
GBT

Global Blood Therapeutics

$68.14 /

-1.33 (-1.91%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBT Global Blood Therapeutics
$68.14 /

-1.33 (-1.91%)

GBT Global Blood Therapeutics
$68.14 /

-1.33 (-1.91%)

05/07/20 Wells Fargo
Global Blood Therapeutics price target raised to $133 from $122 at Wells Fargo
05/07/20 Oppenheimer
Global Blood Therapeutics price target raised to $101 from $88 at Oppenheimer
05/07/20 Cantor Fitzgerald
Global Blood Therapeutics price target raised to $130 from $105
05/06/20 Piper Sandler
Piper says Global Blood Therapeutics Q1 revenues beat 'homerun scenario'
GBT Global Blood Therapeutics
$68.14 /

-1.33 (-1.91%)

GBT Global Blood Therapeutics
$68.14 /

-1.33 (-1.91%)

GBT Global Blood Therapeutics
$68.14 /

-1.33 (-1.91%)

Recommendations
Keros Therapeutics price target raised to $45 from $35 at Piper Sandler » 05:10
05/27/20
05/27
05:10
05/27/20
05:10
KROS

Keros Therapeutics

$26.76 /

-0.74 (-2.69%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KROS Keros Therapeutics
$26.76 /

-0.74 (-2.69%)

KROS Keros Therapeutics
$26.76 /

-0.74 (-2.69%)

05/04/20
Fly Intel: Top five analyst initiations
05/04/20 H.C. Wainwright
Keros Therapeutics initiated with a Buy at H.C. Wainwright
05/04/20 SVB Leerink
Keros Therapeutics initiated with an Outperform at SVB Leerink
05/04/20 Jefferies
Keros Therapeutics initiated with a Buy at Jefferies
KROS Keros Therapeutics
$26.76 /

-0.74 (-2.69%)

KROS Keros Therapeutics
$26.76 /

-0.74 (-2.69%)

Downgrade
Fraport downgraded to Sell from Neutral at Goldman Sachs » 05:08
05/27/20
05/27
05:08
05/27/20
05:08
FPRUF

Fraport

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FPRUF Fraport
$0.00 /

+ (+0.00%)

05/14/20 Societe Generale
Fraport downgraded to Hold from Buy at Societe Generale
04/02/20 MainFirst
Fraport downgraded to Hold from Buy at MainFirst
03/19/20 JPMorgan
Fraport price target lowered to EUR 48 from EUR 70 at JPMorgan
03/11/20 Goldman Sachs
Fraport upgraded to Neutral from Sell at Goldman Sachs
Upgrade
Aena upgraded to Buy from Sell at Goldman Sachs » 05:06
05/27/20
05/27
05:06
05/27/20
05:06
ANNSF

Aena

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANNSF Aena
$0.00 /

+ (+0.00%)

05/14/20 Societe Generale
Aena upgraded to Buy from Hold at Societe Generale
05/14/20 Societe Generale
Aena upgraded to Buy from Hold at Societe Generale
05/06/20 JPMorgan
Aena price target lowered to EUR 111 from EUR 112 at JPMorgan
04/30/20 Barclays
Aena price target lowered to EUR 110 from EUR 115 at Barclays
Recommendations
MGM Holdings price target raised to $107 from $98 at Imperial Capital » 05:02
05/27/20
05/27
05:02
05/27/20
05:02
MGMB

MGM Holdings

$0.00 /

+ (+0.00%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGMB MGM Holdings
$0.00 /

+ (+0.00%)

03/06/20 Imperial Capital
MGM Holdings price target raised to $132 from $119 at Imperial Capital
Downgrade
FirstEnergy downgraded to Neutral from Buy at Mizuho » 05:01
05/27/20
05/27
05:01
05/27/20
05:01
FE

FirstEnergy

$40.71 /

+0.06 (+0.15%)

Mizuho analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FE FirstEnergy
$40.71 /

+0.06 (+0.15%)

FE FirstEnergy
$40.71 /

+0.06 (+0.15%)

05/20/20 Seaport Global
FirstEnergy initiated with a Buy at Seaport Global
05/20/20 Seaport Global
FirstEnergy initiated with a Buy at Seaport Global
04/24/20 Wells Fargo
FirstEnergy price target lowered to $50 from $59 at Wells Fargo
03/23/20 Morgan Stanley
Morgan Stanley sees selective opportunities in U.S. utilities, changes 4 ratings
FE FirstEnergy
$40.71 /

+0.06 (+0.15%)

FE FirstEnergy
$40.71 /

+0.06 (+0.15%)

Downgrade
Bio-Techne downgraded to Hold from Buy at Stifel » 05:00
05/27/20
05/27
05:00
05/27/20
05:00
TECH

Bio-Techne

$260.34 /

-6.46 (-2.42%)

Stifel analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TECH Bio-Techne
$260.34 /

-6.46 (-2.42%)

TECH Bio-Techne
$260.34 /

-6.46 (-2.42%)

05/14/20 Benchmark
Benchmark sees 'multiple ways to play COVID-19' for Bio-Techne, starts at Buy
05/14/20 Benchmark
Bio-Techne initiated with a Buy at Benchmark
04/20/20 Craig-Hallum
Bio-Techne price target lowered to $211 from $218 at Craig-Hallum
03/30/20 Wells Fargo
Bio-Techne price target lowered to $190 from $225 at Wells Fargo
TECH Bio-Techne
$260.34 /

-6.46 (-2.42%)

Upgrade
Eurofins Scientific upgraded to Buy from Hold at Jefferies » 04:57
05/27/20
05/27
04:57
05/27/20
04:57
ERFSF

Eurofins Scientific

$0.00 /

+ (+0.00%)

Jefferies analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERFSF Eurofins Scientific
$0.00 /

+ (+0.00%)

03/11/20 Morgan Stanley
Eurofins Scientific upgraded to Equal Weight from Underweight at Morgan Stanley
02/14/20 Deutsche Bank
Eurofins Scientific initiated with a Sell at Deutsche Bank
01/16/20 Exane BNP Paribas
Eurofins downgraded to Underperform from Neutral at Exane BNP Paribas
Upgrade
Rockwool upgraded to Overweight from Underweight at Barclays » 04:56
05/27/20
05/27
04:56
05/27/20
04:56
RKWBF

Rockwool

$0.00 /

+ (+0.00%)

Barclays analyst Pierre…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RKWBF Rockwool
$0.00 /

+ (+0.00%)

05/19/20 Barclays
Rockwool price target lowered to DKK 1,250 from DKK 1,290 at Barclays
05/18/20 Morgan Stanley
Rockwool upgraded to Equal Weight from Underweight at Morgan Stanley
General news
Week of 5/22 MBA Mortgage Applications to be released at 07:00  04:55
05/27/20
05/27
04:55
05/27/20
04:55
 
General news
St. Louis Federal Reserve Bank President James Bullard Speech to be released at 12:30  04:55
05/27/20
05/27
04:55
05/27/20
04:55
 
Conference/Events
Store Capital to host conference call » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
STOR

Store Capital

$19.96 /

+1.235 (+6.60%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STOR Store Capital
$19.96 /

+1.235 (+6.60%)

STOR Store Capital
$19.96 /

+1.235 (+6.60%)

05/20/20 Raymond James
Store Capital price target lowered to $27 from $42 at Raymond James
05/04/20 Morgan Stanley
Morgan Stanley shakes up REIT ratings with Realty Income upgrade, two downgrades
05/04/20 Morgan Stanley
Store Capital downgraded to Equal Weight from Overweight at Morgan Stanley
04/24/20 Mizuho
Store Capital downgraded to Neutral from Buy at Mizuho
STOR Store Capital
$19.96 /

+1.235 (+6.60%)

STOR Store Capital
$19.96 /

+1.235 (+6.60%)

STOR Store Capital
$19.96 /

+1.235 (+6.60%)

Conference/Events
Alibaba management to meet virtually with Oppenheimer » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
BABA

Alibaba

$201.77 /

+2.185 (+1.09%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BABA Alibaba
$201.77 /

+2.185 (+1.09%)

BABA Alibaba
$201.77 /

+2.185 (+1.09%)

05/26/20 Susquehanna
Alibaba price target raised to $275 from $260 at Susquehanna
05/26/20 RBC Capital
Alibaba price target raised to $235 from $230 at RBC Capital
05/26/20 Mizuho
Alibaba price target raised to $260 from $255 at Mizuho
05/26/20 Nomura Instinet
Alibaba price target raised to $249 from $240 at Nomura Instinet
BABA Alibaba
$201.77 /

+2.185 (+1.09%)

BABA Alibaba
$201.77 /

+2.185 (+1.09%)

BABA Alibaba
$201.77 /

+2.185 (+1.09%)

BABA Alibaba
$201.77 /

+2.185 (+1.09%)

Conference/Events
Freshpet management to meet virtually with Oppenheimer » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
FRPT

Freshpet

$70.77 /

-0.32 (-0.45%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$70.77 /

-0.32 (-0.45%)

FRPT Freshpet
$70.77 /

-0.32 (-0.45%)

05/11/20
Fly Intel: Top five analyst initiations
05/11/20 Citi
Freshpet initiated with a Neutral at Citi
05/05/20 SunTrust
Freshpet price target raised to $60 from $55 at SunTrust
04/21/20 BofA
Freshpet initiated with a Neutral at BofA
FRPT Freshpet
$70.77 /

-0.32 (-0.45%)

FRPT Freshpet
$70.77 /

-0.32 (-0.45%)

Conference/Events
Bellus Health to hold a virtual KOL meeting » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
BLU

Bellus Health

$10.44 /

+0.12 (+1.16%)

Virtual KOL Meeting with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLU Bellus Health
$10.44 /

+0.12 (+1.16%)

BLU Bellus Health
$10.44 /

+0.12 (+1.16%)

01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
09/30/19
Fly Intel: Top five analyst initiations
09/30/19 Jefferies
Jefferies sees potential double in Bellus Health, starts shares at Buy
09/30/19 Guggenheim
Guggenheim starts Bellus Health at Buy with $12 price target
Conference/Events
Zendesk participates in a conference call with RBC Capital » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
ZEN

Zendesk

$81.16 /

-0.81 (-0.99%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZEN Zendesk
$81.16 /

-0.81 (-0.99%)

ZEN Zendesk
$81.16 /

-0.81 (-0.99%)

05/01/20 Piper Sandler
Zendesk downgraded to Neutral from Overweight at Piper Sandler
05/01/20 Jefferies
Zendesk price target raised to $85 from $80 at Jefferies
04/28/20 Evercore ISI
Zendesk downgraded to In Line from Outperform at Evercore ISI
04/27/20 Craig-Hallum
Zendesk price target lowered to $95 from $110 at Craig-Hallum
ZEN Zendesk
$81.16 /

-0.81 (-0.99%)

ZEN Zendesk
$81.16 /

-0.81 (-0.99%)

Conference/Events
CytoSorbents management to meet virtually with B. Riley FBR » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
CTSO

CytoSorbents

$10.50 /

+0.08 (+0.77%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
CTSO CytoSorbents
$10.50 /

+0.08 (+0.77%)

CTSO CytoSorbents
$10.50 /

+0.08 (+0.77%)

05/14/20 B. Riley FBR
CytoSorbents label expansion could significantly expand use, says B. Riley FBR
05/06/20 B. Riley FBR
B. Riley boosts CytoSorbents target, says Portola deal highlights value
03/25/20 Dawson James
CytoSorbents being used for COVID-19 in Italy, China, says Dawson James
01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
CTSO CytoSorbents
$10.50 /

+0.08 (+0.77%)

CTSO CytoSorbents
$10.50 /

+0.08 (+0.77%)

Conference/Events
Magellan Health participates in a conference call with Stephens » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
MGLN

Magellan Health

$70.77 /

-0.48 (-0.67%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGLN Magellan Health
$70.77 /

-0.48 (-0.67%)

MGLN Magellan Health
$70.77 /

-0.48 (-0.67%)

11/11/19 Jefferies
Magellan Health should trade higher on California win, says Jefferies
11/11/19 Stephens
Magellan Health price target raised to $67 after CA PBM win at Stephens
10/01/19 Stephens
Stephens lowers price targets for MCOs on 2020 election uncertainty
07/11/19 Stephens
Stephens raises targets for Anthem, Cigna, peers on HHS rebate rule withdrawal
MGLN Magellan Health
$70.77 /

-0.48 (-0.67%)

Conference/Events
CNO Financial participates in a conference call hosted by B. Riley FBR » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
CNO

CNO Financial

$14.20 /

+0.89 (+6.69%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNO CNO Financial
$14.20 /

+0.89 (+6.69%)

CNO CNO Financial
$14.20 /

+0.89 (+6.69%)

05/20/20
Fly Intel: Top five analyst initiations
05/20/20 Piper Sandler
CNO Financial initiated with a Neutral at Piper Sandler
03/11/20 B. Riley FBR
B. Riley FBR downgrades CNO Financial, Progressive to Neutral from Buy
03/11/20 B. Riley FBR
CNO Financial downgraded to Neutral from Buy at B. Riley FBR
CNO CNO Financial
$14.20 /

+0.89 (+6.69%)

Conference/Events
Amerisafe management to virtually meet with JMP Securities » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
AMSF

Amerisafe

$62.39 /

+0.29 (+0.47%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMSF Amerisafe
$62.39 /

+0.29 (+0.47%)

AMSF Amerisafe
$62.39 /

+0.29 (+0.47%)

02/21/20 SunTrust
Amerisafe price target raised to $87 from $79 at SunTrust
02/20/20 JMP Securities
Amerisafe price target raised to $80 from $70 at JMP Securities
11/22/19 B. Riley FBR
Amerisafe price target raised to $81 from $75 at B. Riley FBR
AMSF Amerisafe
$62.39 /

+0.29 (+0.47%)

Conference/Events
Biohaven Pharmaceutical management to meet with Cantor Fitzgerald » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
BHVN

Biohaven Pharmaceutical

$60.00 /

+1.615 (+2.77%)

Healthcare Analyst Duncan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$60.00 /

+1.615 (+2.77%)

BHVN Biohaven Pharmaceutical
$60.00 /

+1.615 (+2.77%)

05/22/20 Piper Sandler
Growth of Biohaven's Nurtec continues to beat AbbVie's Ubrelvy, says Piper
05/20/20 Mizuho
Biohaven withdrawal of rimegepant NDA in line with plan, says Mizuho
05/11/20 Cantor Fitzgerald
Biohaven Pharmaceutical price target raised to $82 from $75 at Cantor Fitzgerald
04/17/20 Cowen
Cowen initiates Biohaven Pharmaceutical with Outperform on migraine opportunity
BHVN Biohaven Pharmaceutical
$60.00 /

+1.615 (+2.77%)

BHVN Biohaven Pharmaceutical
$60.00 /

+1.615 (+2.77%)

BHVN Biohaven Pharmaceutical
$60.00 /

+1.615 (+2.77%)

BHVN Biohaven Pharmaceutical
$60.00 /

+1.615 (+2.77%)

Conference/Events
Dolby management to meet virtually with B.Riley FBR » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
DLB

Dolby

$60.65 /

+1.96 (+3.34%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DLB Dolby
$60.65 /

+1.96 (+3.34%)

DLB Dolby
$60.65 /

+1.96 (+3.34%)

04/15/20 B. Riley FBR
Dolby price target raised to $71 from $60 at B. Riley FBR
03/26/20 Barrington
Dolby price target lowered to $70 from $85 at Barrington
03/24/20 B. Riley FBR
Dolby upgraded to Buy from Neutral at B. Riley FBR
03/13/20 JPMorgan
JPMorgan upgrades 'relatively safe' Dolby to Overweight after 22% pullback
DLB Dolby
$60.65 /

+1.96 (+3.34%)

Conference/Events
Unilever participates in a conference call with Goldman Sachs » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
UN

Unilever

$48.28 /

+0.26 (+0.54%)

, UL

Unilever

$51.06 /

+0.28 (+0.55%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UN Unilever
$48.28 /

+0.26 (+0.54%)

UL Unilever
$51.06 /

+0.28 (+0.55%)

UN Unilever
$48.28 /

+0.26 (+0.54%)

05/04/20 JPMorgan
Unilever NV price target raised to EUR 48 from EUR 42 at JPMorgan
04/28/20 DZ Bank
Unilever downgraded to Hold from Buy at DZ Bank
04/15/20 Credit Suisse
Unilever price target lowered to EUR 54 from EUR 56.50 at Credit Suisse
04/07/20 Morgan Stanley
Unilever double downgraded to Underweight at Morgan Stanley
UL Unilever
$51.06 /

+0.28 (+0.55%)

05/04/20 JPMorgan
Unilever price target raised to 4,300 GBp from 3,850 GBp at JPMorgan
04/28/20 DZ Bank
Unilever downgraded to Hold from Buy at DZ Bank
04/15/20 Credit Suisse
Unilever price target lowered to EUR 54 from EUR 56.50 at Credit Suisse
04/08/20 HSBC
Unilever upgraded to Hold from Reduce at HSBC
UN Unilever
$48.28 /

+0.26 (+0.54%)

UL Unilever
$51.06 /

+0.28 (+0.55%)

UN Unilever
$48.28 /

+0.26 (+0.54%)

UL Unilever
$51.06 /

+0.28 (+0.55%)

Conference/Events
Preferred Apartment management to meet with JMP Securities » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
APTS

Preferred Apartment

$7.82 /

+0.555 (+7.64%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APTS Preferred Apartment
$7.82 /

+0.555 (+7.64%)

APTS Preferred Apartment
$7.82 /

+0.555 (+7.64%)

02/26/20 National Securities
Preferred Apartment downgraded to Neutral from Buy at National Securities
11/05/19 Compass Point
Preferred Apartment downgraded to Hold from Buy at Compass Point
09/16/19
Fly Intel: Top five analyst initiations
09/16/19 National Securities
Preferred Apartment initiated with a Buy at National Securities
APTS Preferred Apartment
$7.82 /

+0.555 (+7.64%)

General news
May Beige Book to be released at 14:00  04:55
05/27/20
05/27
04:55
05/27/20
04:55
 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.